List of Excipients in API perampanel
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing perampanel
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Eisai Inc | FYCOMPA | perampanel | 62856-272 | FERRIC OXIDE RED | 2026-07-01 |
Eisai Inc | FYCOMPA | perampanel | 62856-272 | FERRIC OXIDE YELLOW | 2026-07-01 |
Eisai Inc | FYCOMPA | perampanel | 62856-272 | HYPROMELLOSES | 2026-07-01 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for perampanel
Excipient focus: FERRIC OXIDE RED
perampanel drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
perampanel drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
perampanel drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
perampanel drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
perampanel drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
perampanel drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
perampanel drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
perampanel drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
perampanel drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
perampanel drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Eisai Inc | perampanel | 62856-272 |
Catalyst Pharmaceuticals Inc | perampanel | 69616-272 |
>Company | >Ingredient | >NDC |
perampanel drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.